Everett Cunningham - 01 Mar 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Reporting relationship: Chief Commercial Officer
Issuer ticker: EXAS
Reported as of: 01 Mar 2023
Net transaction value: -$224,972
SEC form: 4
Accepted by SEC: 02 Mar 2023, 15:07:20 UTC
Prior SEC filing: 01 Mar 2023
Next SEC filing: 20 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact

Key filing fact

Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 02 Mar 2023.

Key facts

This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Mar 2023, 15:07.

Change

Previous filing in this sequence was filed on 01 Mar 2023.
Current net transaction value: -$224,972.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXAS transaction

Common Stock

Sale

Transaction value: $224,972
Shares: -3,628
Change %: -14%
Price: $62.01
Shares after: 22,703
Date: 01 Mar 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2023.

Footnote F2

In addition to the shares of Common Stock reported on this Form 4, which total 22,703 shares, Mr. Cunningham also holds, in the aggregate, an additional 99,211 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.